What CMS data reveal about urology practice composition

More than a third of urologists work in a urology-dominant practice

Avelumab-based neoadjuvant therapy shows potential in nonmetastatic MIBC

Combining avelumab with standard neoadjuvant chemotherapy induced pathological complete responses in over half of patients with nonmetastatic muscle-invasive bladder cancer.

FDA authorizes AI-based software for prostate cancer detection

Paige Prostate AI-based software provides pathologists with a supplementary assessment of prostate biopsy images that identifies the area with the highest likelihood of harboring cancer.